MedTech Dive March 7, 2024
The new sensor is designed to last for 14 days but requires finger-stick calibration.
Dive Brief:
- Roche shared details of its plans to enter the continuous glucose monitor (CGM) market, unveiling the Accu-Chek Smartguide at the Advanced Technologies and Treatments for Diabetes conference in Florence, Italy.
- On Thursday, the company released data on a 14-day sensor that could compete with Abbott and Dexcom for the CGM market. Roche is working to get a CE mark and plans to sell the device in “selected European countries” soon after receiving clearance.
- BTIG and J.P. Morgan analysts do not see Roche’s CGM as a major threat to Abbott and Dexcom, in part because, unlike the incumbents, the new device requires...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices